Ask about the preparation
A practical NAD+ reading guide focused on formulation, pharmacy questions and the limits of a general safety warning, with transparent status for unverified Cyber Monday promotions.
Explore the detailsTake this with you
What exact NAD+ preparation is being proposed, and why is it being considered?
Which pharmacy would prepare and dispense a prescribed product?
How can the pharmacy explain ingredient suitability and the product information it provides?
Who would answer questions about the dispensing label, storage or an unexpected reaction?
A closer look
A product name and a starting price cannot describe every part of a compounded preparation. This workbook helps organize questions about the proposed NAD+ product, its dispensing pharmacy and the information a clinician should explain. It also places FDA’s sterile-compounding warning in context without treating that general warning as a finding about a particular provider.
This site promotes CoreAge Rx. No NAD+ holiday discount or Cyber Monday offer was verified as of November 7, 2026. Verified Black Friday offers for other products end November 27, before Cyber Monday on November 30. The current NAD+ listing is commercial information; suitability, formulation and order terms still need confirmation.
The reading room
Understand what FDA’s warning says about sterile-compounding ingredients, what it does not establish about a provider and which questions it can help frame.
Give clinical, pharmacy and billing questions a clear destination so an answer about one part of an NAD+ offering does not substitute for another.
Sponsored · CoreAge Rx
A Cyber Monday promotion has not been verified. The links below show current provider pages; Black Friday terms do not establish a Cyber Monday offer.
Regular product listing
Provider-advertised starting price
No Black Friday or Cyber Monday discount has been verified. Confirm the total plan cost and current terms with CoreAge Rx.
Compounded medication is not FDA-approved. A clinician must assess your needs; a prescription is not guaranteed.
Provider sourcePromotional placement. This publication is part of a commonly owned promotional network supporting CoreAge Rx. Placement is not an independent ranking or a claim that treatment is appropriate for you. How this site works.
Before you decide
FDA warns about unsuitable food-grade NAD+ ingredients used in sterile compounding and describes reported reactions consistent with endotoxin contamination. This is a warning about compounding practices. It is not evidence that CoreAge Rx or its pharmacies supplied a contaminated product.
No. CoreAge Rx describes its NAD+ offering as compounded, and compounded preparations do not receive FDA premarket approval. Ask a clinician to explain the proposed preparation and why it is being considered for your needs rather than inferring approval from a provider listing.
CoreAge Rx’s general NAD+ Injectable listing advertises a starting price of $93 per month. A complete checkout price and minimum commitment were not established. No NAD+ holiday discount was verified, so that figure should not be presented as Monday savings.
No. It organizes questions rather than predicting energy, cognition or aging outcomes. A clinician should evaluate the concern and discuss evidence, limitations and alternatives. Public product descriptions do not establish an individual response to a proposed compounded preparation.